Navigation Links
TVM Capital MENA Marks Inauguration of ProVita International Medical Center

DUBAI, UAE, October 12, 2011 /PRNewswire/ --

TVM Capital MENA has today inaugurated its first investment in the MENA region.

The official opening of ProVita International Medical Center in Abu Dhabi was attended by TVM Capital MENA Chairman & CEO Dr. Helmut M. Schuehsler who also serves as Chairman of the Board at ProVita. The region's first long-term care facility for acute, ventilator dependent patients in a non-hospital setting, ProVita addresses a significant market need in the region. The facility offers round the clock care for acute ventilator dependent patients outside of the Intensive Care Unit (ICU) where they usually have to live, if no such facilities as ProVita exist.

The genesis of the clinic, and more specifically the collaboration with the founder of ProVita clinics in Germany, Christina Shawky-Boehme, is consistent with the TVM Capital MENA strategy of involving leading operators from more fully developed healthcare markets such as in Europe or North America to provide unique and specialized healthcare services in the Middle East, directly catering to the growing local demand. The investment in ProVita was originally announced in November 2010 and the facility was eventually opened in February 2011. The company hopes to meet enough demand in other countries to be able to open additional long-term care facilities in the region, including the Kingdom of Saudi Arabia.

According to Dr. Helmut M. Schuehsler, Chairman & CEO of TVM Capital MENA, '' We are proud of the work that ProVita has been able to do and the difference it has made to the quality of life of severely ill and ventilator dependent patients in Abu Dhabi. The facility is a first for the region and a testament to the growth and development of the local healthcare industry. The demand for long-term care remains high and we hope to expand the ProVita offering throughout the region.'’

TVM Capital MENA is the first international private equity house with a focus in healthcare to establish operations in the MENA region. The three founding investors of the TVM Capital MENA Healthcare Private Equity Fund are the IFC (International Financing Corporation), GE Healthcare and The Olayan Group.

The second TVM Capital MENA investment in the region, Bourn Hall International, had a soft opening of its first in-vitro-fertilization (IVF) clinic in Kochi, Kerala, India in July 2011 and is currently building out additional facilities in Delhi and Dubai. The founders of BHI invented IVF in 1978 with the first successful birth of a child conceived through an IVF procedure. As the ultimate testament of Bourn Hall's world-leading expertise in the field of fertility, its founder, Dr. Bob Edwards, was awarded in 2010 the Nobel Prize in medicine for the invention of IVF.

Notes to editor

TVM Capital MENA Ltd. is a private equity firm focusing on investments in health care in the Middle East and North Africa (MENA).  TVM Capital MENA operates out of the Dubai International Financial Center and is licensed and regulated by the DFSA.  The team of TVM Capital MENA is affiliated to the international Life Science Practice of TVM Capital. The TVM Capital Life Science Practice currently manages €820 million from more than 50 investors. The investment professionals draw upon the experience, international approach and demonstrated success of about 80 exits from almost 120 investments. Exits include nearly 40 initial public offerings on the NASDAQ, and the London, Frankfurt, Zurich and Vienna Stock Exchanges and 25 trade sales and mergers. TVM Capital Life Science operates with an integrated team from its headquarters in Munich and a representative office in Boston. The team combines long-standing international investment experience and operating track records with extensive networks in and knowledge of the MENA region.

More information please visit:

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
2. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
3. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
6. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
7. Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
8. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
9. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
10. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
11. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... of the year and one of the premier annual events for pharmaceutical manufacturing: ... from 8–11 November 2015, where ISPE hosted the largest number of attendees in ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
Breaking Biology Technology:
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/29/2015)... YORK , Oct. 29, 2015 ... technology, announced a partnership with 2XU, a global ... to deliver a smart hat with advanced bio-sensing ... and other athletes to monitor key biometrics to ... the strategic partnership, the two companies will bring together ...
(Date:10/27/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leader ... adopted the Synaptics ® ClearPad ® Series ... newest flagship smartphones, the Nexus 5X by LG and ... --> --> Synaptics works closely with ... in the joint development of next generation technologies. Together, ...
Breaking Biology News(10 mins):